6-87518718-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_020320.5(RARS2):āc.1327T>Cā(p.Ser443Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000254 in 1,614,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020320.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152170Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251374Hom.: 0 AF XY: 0.0000662 AC XY: 9AN XY: 135858
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461836Hom.: 0 Cov.: 32 AF XY: 0.0000275 AC XY: 20AN XY: 727226
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152170Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
Pontocerebellar hypoplasia type 6 Pathogenic:2
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.006%). Predicted Consequence/Location: The majority of the known disease-causing variants of this gene are variants expected to result in premature termination of the protein. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.60 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.91 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000402195 /PMID: 26539891). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
not provided Pathogenic:1Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 34426522, Ginevrino2019[thesis], 26539891, 34085948, 26968897, 32585800, 39230874) -
This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 443 of the RARS2 protein (p.Ser443Pro). This variant is present in population databases (rs775295739, gnomAD 0.02%). This missense change has been observed in individual(s) with pontocerebellar hypoplasia (PMID: 26539891, 34085948). ClinVar contains an entry for this variant (Variation ID: 402195). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RARS2 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
RARS2-related disorder Pathogenic:1
The RARS2 c.1327T>C variant is predicted to result in the amino acid substitution p.Ser443Pro. This variant has been reported in the homozygous state in two siblings with Intellectual disability, atrophy of bilateral cerebellum, hypoplastic vermis, seizures (Supp. Figure 1, Table S1A, Karaca et al. 2015. PubMed ID: 26539891). It has also been reported in the compound heterozygous state in an individual with respiratory distress, microcephaly, PMD, epilepsy, and pontocerebellar hypoplasia (Table 1, Legati et al. 2016. PubMed ID: 26968897; Nuovo et al. 2022. PubMed ID: 34085948). It has been reported in the heterozygous state in a presumably healthy individual from the Turkish population (Dataset 4, Kars et al. 2021. PubMed ID: 34426522), as well as in 0.026% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-88228436-A-G). This variant is interpreted as likely pathogenic. -
Abnormal brain morphology Pathogenic:1
- -
Pontoneocerebellar hypoplasia Pathogenic:1
Variant summary: RARS2 c.1327T>C (p.Ser443Pro) results in a non-conservative amino acid change located in the Arginyl-tRNA synthetase, catalytic core domain (IPR035684) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6e-05 in 251374 control chromosomes. c.1327T>C has been reported in the literature as homozygous and compound heterozygous genotype in individuals reportedly affected with features of infantile-onset myoclonic developmental and epleptic encephalopathy/Neurogenetic disorders with brain malfornations/mitochondorial disorders/a neuroradiological diagnosis of Pontocerebellar Hypoplasia (PCH) (example, Karaca_2015, Legati_2016, Matricardi_2019, Nuovo_2022, de Valles-lanez_2022). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as Likely Pathogenic. -
Inborn genetic diseases Uncertain:1
The c.1327T>C (p.S443P) alteration is located in exon 16 (coding exon 16) of the RARS2 gene. This alteration results from a T to C substitution at nucleotide position 1327, causing the serine (S) at amino acid position 443 to be replaced by a proline (P). The c.1327T>C (p.S443P) alteration has been reported homozygous in siblings with features suggestive of pontocerebellar hypoplasia, but the siblings also were reported with a second homozygous alteration in the SNX14 gene that could also explain disease. This alteration was also reported to occur in a patient with pontocerebellar hypoplasia along with a second likely pathogenic alteration affecting the initiation codon; however, phase was not confirmed. The p.S443P alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at